Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ

INTRODUCTION: Ductal carcinoma in situ (DCIS) is a noninvasive premalignant lesion and is considered a precursor to invasive carcinoma. DCIS accounts for nearly 20% of newly diagnosed breast cancer, but the lack of experimentally amenable in vivo DCIS models hinders the development of treatment stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Namba, Ruria, Young, Lawrence JT, Maglione, Jeannie E, McGoldrick, Erik T, Liu, Stephenie, Wurz, Gregory T, DeGregorio, Michael W, Borowsky, Alexander D, MacLeod, Carol L, Cardiff, Robert D, Gregg, Jeffrey P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410776/
https://www.ncbi.nlm.nih.gov/pubmed/16280035
http://dx.doi.org/10.1186/bcr1317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410776/
https://www.ncbi.nlm.nih.gov/pubmed/16280035
http://dx.doi.org/10.1186/bcr1317

Ejemplares similares